# FDA Inspection 676233 - Houston Medical Center Blood Bank - August 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/houston-medical-center-blood-bank/5c81f518-9ee4-4254-821b-92f9c9e1ed9f
Source feed: FDA_Inspections

> FDA Inspection 676233 for Houston Medical Center Blood Bank on August 17, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 676233
- Company Name: Houston Medical Center Blood Bank
- Inspection Date: 2010-08-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 779096 - 2012-04-26](https://www.keypedia.com/records/fda_inspections/houston-medical-center-blood-bank/b03191e4-7515-4dc9-bda7-d1fea4244bf1)
- [FDA Inspection 565241 - 2008-12-31](https://www.keypedia.com/records/fda_inspections/houston-medical-center-blood-bank/474422b7-47be-48a0-a4cf-d57422d78046)

Company: https://www.keypedia.com/companies/houston-medical-center-blood-bank/edadd4fd-acaf-47c5-98aa-3eaf6b9babf0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d